{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:42:33Z","timestamp":1791348153586,"version":"4.3.1"},"publisher-location":"Dordrecht","reference-count":103,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789400773585","type":"print"},{"value":"9789400773592","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T00:00:00Z","timestamp":1379376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T00:00:00Z","timestamp":1379376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-94-007-7359-2_15","type":"book-chapter","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T11:49:24Z","timestamp":1382356164000},"page":"291-323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Carbonic Anhydrase Inhibitors Drug Design"],"prefix":"10.1007","author":[{"given":"Robert","family":"McKenna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,17]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1021\/cr200176r","volume":"112","author":"V Alterio","year":"2012","unstructured":"Alterio V, Di Fiore A, D\u2019Ambrosio K et al (2012) Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms ? Chem Rev 112:4421\u20134468","journal-title":"Chem Rev"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature06636","volume":"452","author":"Y Xu","year":"2008","unstructured":"Xu Y, Feng L, Jeffrey PD, Shi Y, Morel FM (2008) Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms. Nature 452:56\u201361","journal-title":"Nature"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran CT (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 7:168\u2013181","journal-title":"Nat Rev Drug Discov"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrd3554","volume":"10","author":"D Neri","year":"2011","unstructured":"Neri D, Supuran CT (2011) Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 10:767\u2013777","journal-title":"Nat Rev Drug Discov"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","volume":"20","author":"CT Supuran","year":"2010","unstructured":"Supuran CT (2010) Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 20:3467\u20133474","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/14756360410001689540","volume":"19","author":"S Pastorekova","year":"2004","unstructured":"Pastorekova S, Parkkila S, Pastorek J, Supuran CT (2004) Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 19:199\u2013229","journal-title":"J Enzyme Inhib Med Chem"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.4155\/fmc.11.69","volume":"3","author":"CT Supuran","year":"2011","unstructured":"Supuran CT (2011) Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Med Chem 3:1165\u20131180","journal-title":"Future Med Chem"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fphar.2011.00034","volume":"2","author":"CT Supuran","year":"2011","unstructured":"Supuran CT (2011) Bacterial carbonic anhydrases as drug targets: towards novel antibiotics ? Front Pharmacol 2:34","journal-title":"Front Pharmacol"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/med.10025","volume":"23","author":"CT Supuran","year":"2003","unstructured":"Supuran CT, Scozzafava A, Casini A (2003) Carbonic anhydrase inhibitors. Med Res Rev 23:146\u2013189","journal-title":"Med Res Rev"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"30766","DOI":"10.1074\/jbc.M805353200","volume":"283","author":"JF Domsic","year":"2008","unstructured":"Domsic JF, Avvaru BS, Kim CU et al (2008) Entrapment of carbon dioxide in the active site of carbonic anhydrase II. J Biol Chem 283:30766\u201330771","journal-title":"J Biol Chem"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jinorgbio.2011.11.017","volume":"11","author":"G De Simone","year":"2012","unstructured":"De Simone G, Supuran CT (2012) (In)organic anions as carbonic anhydrase inhibitors. J Inorg Biochem 11:117\u2013129","journal-title":"J Inorg Biochem"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3109\/14756366.2012.672983","volume":"27","author":"CT Supuran","year":"2012","unstructured":"Supuran CT (2012) Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 27:759\u2013772","journal-title":"J Enzyme Inhib Med Chem"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1074\/jbc.M510756200","volume":"281","author":"A Suarez Covarrubias","year":"2006","unstructured":"Suarez Covarrubias A, Bergfors T, Jones TA, Hogbom M (2006) Structural mechanics of the pH-dependent activity of the \u03b2-carbonic anhydrase from Mycobacterium tuberculosis. J Biol Chem 281:4993\u20134999","journal-title":"J Biol Chem"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.bmcl.2009.11.124","volume":"20","author":"C Temperini","year":"2010","unstructured":"Temperini C, Scozzafava A, Supuran CT (2010) Carbonic anhydrase inhibitors. X-Ray crystal studies of the carbonic anhydrase II \u2013 trithiocarbonate adduct \u2013 An inhibitor mimicking the sulfonamide and urea binding to the enzyme. Bioorg Med Chem Lett 20:474\u2013478","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"10384","DOI":"10.1021\/bi970760v","volume":"36","author":"F Briganti","year":"1997","unstructured":"Briganti F, Mangani S, Orioli P, Scozzafava A, Vernaglione G, Supuran CT (1997) Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. Biochemistry 36:10384\u201311039","journal-title":"Biochemistry"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.1002\/chem.200600159","volume":"12","author":"C Temperini","year":"2006","unstructured":"Temperini C, Scozzafava A, Vullo D, Supuran CT (2006) Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII and XIV with L- and D-histidine and crystallographic analysis of their adducts with isoform II: engineering proton transfer processes within the active site of an enzyme. Chemistry 12:7057\u20137066","journal-title":"Chemistry"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"6223","DOI":"10.1021\/ja1097594","volume":"133","author":"CM Maupin","year":"2011","unstructured":"Maupin CM, Castillo N, Taraphder S, Tu C, McKenna R, Silverman DN, Voth GA (2011) Chemical rescue of enzymes: proton transfer in mutants of human carbonic anhydrase II. J Am Chem Soc 133:6223\u20136234","journal-title":"J Am Chem Soc"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1021\/jm1003667","volume":"53","author":"F Carta","year":"2010","unstructured":"Carta F, Temperini C, Innocenti A, Scozzafava A, Kaila K, Supuran CT (2010) Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. J Med Chem 53:5511\u20135522","journal-title":"J Med Chem"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1021\/ja809683v","volume":"131","author":"A Maresca","year":"2009","unstructured":"Maresca A, Temperini C, Vu H, Pham NB, Poulsen SA, Scozzafava A, Quinn RJ, Supuran CT (2009) Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 131:3057\u20133062","journal-title":"J Am Chem Soc"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1021\/jm901287j","volume":"53","author":"A Maresca","year":"2010","unstructured":"Maresca A, Temperini C, Pochet L, Masereel B, Scozzafava A, Supuran CT (2010) Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem 53:335\u2013344","journal-title":"J Med Chem"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"8271","DOI":"10.1021\/jm200983e","volume":"54","author":"N Touisni","year":"2011","unstructured":"Touisni N, Maresca A, McDonald PC, Lou Y, Scozzafava A, Dedhar S, Winum JY, Supuran CT (2011) Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. J Med Chem 54:8271\u20138277","journal-title":"J Med Chem"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/cmdc.201100288","volume":"6","author":"LW Woo","year":"2011","unstructured":"Woo LW, Ganeshapillai D, Thomas MP, Sutcliffe OB, Malini B, Mahon MF, Purohit A, Potter BV (2011) Structure-activity relationship for the first-in-class clinical steroid sulfatase inhibitor Irosustat (STX64, BN83495). ChemMedChem 6:2019\u20132034","journal-title":"ChemMedChem"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1016\/j.bmc.2007.04.020","volume":"15","author":"CT Supuran","year":"2007","unstructured":"Supuran CT, Scozzafava A (2007) Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 15:4336\u20134350","journal-title":"Bioorg Med Chem"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3109\/14756360903571685","volume":"25","author":"L Baranauskien\u0117","year":"2010","unstructured":"Baranauskien\u0117 L, Hilvo M, Matulien\u0117 J, Golovenko D, Manakova E, Dudutien\u0117 V, Michailovien\u0117 V, Torresan J, Jachno J, Parkkila S, Maresca A, Supuran CT, Gra\u017eulis S, Matulis D (2010) Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo(1,2-c)(1,2,3)thiadiazole-7-sulphonamides. J Enzyme Inhib Med Chem 25:863\u2013870","journal-title":"J Enzyme Inhib Med Chem"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1016\/j.bmcl.2004.09.085","volume":"14","author":"S Zimmerman","year":"2004","unstructured":"Zimmerman S, Innocenti A, Casini A, Ferry JG, Scozzafava A, Supuran CT (2004) Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides. Bioorg Med Chem Lett 14:6001\u20136006","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jmb.2008.11.037","volume":"385","author":"C Schlicker","year":"2009","unstructured":"Schlicker C, Hall RA, Vullo D, Middelhaufe S, Gertz M, Supuran CT, Muhlschlegel FA, Steegborn C (2009) Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans. J Mol Biol 385:1207\u20132020","journal-title":"J Mol Biol"},{"key":"15_CR27","first-page":"102","volume":"20","author":"F Pacchiano","year":"2010","unstructured":"Pacchiano F, Carta F, Vullo D, Scozzafava A, Supuran CT (2010) Inhibition of \u03b2-carbonic anhydrases with ureido-substituted benzenesulfonamides. Bioorg Med Chem Lett 20:102\u2013105","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"16233","DOI":"10.1073\/pnas.0908301106","volume":"106","author":"V Alterio","year":"2009","unstructured":"Alterio V, Hilvo M, Di Fiore A et al (2009) Crystal structure of the extracellular catalytic domain of the tumor-associated human carbonic anhydrase IX. Proc Natl Acad Sci U S A 106:16233\u201316238","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1021\/jm030912m","volume":"47","author":"A Weber","year":"2004","unstructured":"Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A, Klebe G (2004) Unexpected nanomolar inhibition of carbonic anhydrase by COX-2 selective Celecoxib: new pharmacological opportunities due to related binding site recognition. J Med Chem 47:550\u2013557","journal-title":"J Med Chem"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bmcl.2005.09.040","volume":"16","author":"A Di Fiore","year":"2006","unstructured":"Di Fiore A, Pedone C, D\u2019Ambrosio K, Scozzafava A, De Simone G, Supuran CT (2006) Carbonic anhydrase inhibitors: valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related, cyclooxygenase II \u201cselective\u201d inhibitor celecoxib. Bioorg Med Chem Lett 16:437\u2013442","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"7697","DOI":"10.1002\/anie.200701189","volume":"46","author":"K K\u00f6hler","year":"2007","unstructured":"K\u00f6hler K, Hillebrecht A, Schulze Wischeler J, Innocenti A, Heine A, Supuran CT, Klebe G (2007) Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste. Angew Chem Int Ed Engl 46:7697\u20137699","journal-title":"Angew Chem Int Ed Engl"},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"672","DOI":"10.2174\/138161208783877811","volume":"14","author":"M Hilvo","year":"2008","unstructured":"Hilvo M, Innocenti A, Monti SM, De Simone G, Supuran CT, Parkkila S (2008) Recent advances in research on the most novel carbonic anhydrases, CA XIII and XV. Curr Pharm Des 14:672\u2013678","journal-title":"Curr Pharm Des"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/prot.22144","volume":"74","author":"A Di Fiore","year":"2009","unstructured":"Di Fiore A, Monti SM, Hilvo M, Di Fiore A, Monti SM, Hilvo M, Parkkila S, Romano V, Scaloni A, Pedone C, Scozzafava A, Supuran CT, De Simone G (2009) Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide. Proteins 74:164\u2013175","journal-title":"Proteins"},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1016\/j.bmcl.2010.07.051","volume":"20","author":"A Di Fiore","year":"2010","unstructured":"Di Fiore A, Truppo E, Supuran CT, Alterio V, Dathan N, Bootorabi F, Parkkila S, Monti SM, De Simone G (2010) Crystal structure of the C183S\/C217S mutant of human CA VII in complex with acetazolamide. Bioorg Med Chem Lett 20:5023\u20135026","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR35","doi-asserted-by":"publisher","first-page":"9545","DOI":"10.1073\/pnas.161301298","volume":"98","author":"DA Whittington","year":"2001","unstructured":"Whittington DA, Waheed A, Ulmasov B et al (2001) Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells. Proc Natl Acad Sci U S A 98:9545\u20139550","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR36","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1074\/jbc.M310809200","volume":"279","author":"DA Whittington","year":"2004","unstructured":"Whittington DA, Grubb JH, Waheed A, Shah GN, Sly WS, Christianson DW (2004) Expression, assay, and structure of the extracellular domain of murine carbonic anhydrase XIV: implications for selective inhibition of membrane-associated isozymes. J Biol Chem 279:7223\u20137228","journal-title":"J Biol Chem"},{"key":"15_CR37","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1021\/jm001051+","volume":"43","author":"A Casini","year":"2000","unstructured":"Casini A, Scozzafava A, Mincione F, Menabuoni L, Ilies MA, Supuran CT (2000) Carbonic anhydrase inhibitors: water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects. J Med Chem 43:4884\u20134892","journal-title":"J Med Chem"},{"key":"15_CR38","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1021\/jm0108202","volume":"45","author":"A Scozzafava","year":"2002","unstructured":"Scozzafava A, Menabuoni L, Mincione F, Supuran CT (2002) Carbonic anhydrase inhibitors. A general approach for the preparation of water soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long lasting, topical intraocular pressure lowering properties. J Med Chem 45:1466\u20131476","journal-title":"J Med Chem"},{"key":"15_CR39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/14756366.2011.597749","volume":"27","author":"F Fabrizi","year":"2012","unstructured":"Fabrizi F, Mincione F, Somma T, Scozzafava G, Galassi F, Masini E, Impagnatiello F, Supuran CT (2012) A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology. J Enzyme Inhib Med Chem 27:138\u2013147","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"S1","key":"15_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14756360902784425","volume":"24","author":"P Ebbesen","year":"2009","unstructured":"Ebbesen P, Pettersen EO, Gorr TA, Jobst G, Williams K, Kieninger J, Wenger RH, Pastorekova S, Dubois L, Lambin P, Wouters BG, Van Den Beucken T, Supuran CT, Poellinger L, Ratcliffe P, Kanopka A, G\u00f6rlach A, Gasmann M, Harris AL, Maxwell P, Scozzafava A (2009) Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies. J Enzyme Inhib Med Chem 24(S1):1\u201339","journal-title":"J Enzyme Inhib Med Chem"},{"key":"15_CR41","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","volume":"577","author":"E \u0160vastov\u00e1","year":"2004","unstructured":"\u0160vastov\u00e1 E, Hul\u00edkov\u00e1 A, Rafajov\u00e1 M, Zat'ovicov\u00e1 M, Gibadulinov\u00e1 A, Casini A, Cecchi A, Scozzafava A, Supuran CT, Pastorek J, Pastorekov\u00e1 S (2004) Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 577:439\u2013445","journal-title":"FEBS Lett"},{"key":"15_CR42","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.radonc.2009.06.019","volume":"92","author":"L Dubois","year":"2009","unstructured":"Dubois L, Lieuwes NG, Maresca A et al (2009) Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumor model. Radiother Oncol 92:423\u2013428","journal-title":"Radiother Oncol"},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1016\/j.bmcl.2009.06.022","volume":"19","author":"JKJ Ahlskog","year":"2009","unstructured":"Ahlskog JKJ, Dumelin CE, Tr\u00fcssel S, Marlind J, Neri D (2009) In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives. Bioorg Med Chem Lett 19:4851\u20134856","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","volume":"71","author":"Y Lou","year":"2011","unstructured":"Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A, Kyle A, Auf dem Keller U, Leung S, Huntsman D, Clarke B, Sutherland BW, Waterhouse D, Bally M, Roskelley C, Overall CM, Minchinton A, Pacchiano F, Carta F, Scozzafava A, Touisni N, Winum JY, Supuran CT, Dedhar S (2011) Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 71:3364\u20133376","journal-title":"Cancer Res"},{"key":"15_CR45","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1021\/jm101541x","volume":"54","author":"F Pacchiano","year":"2011","unstructured":"Pacchiano F, Carta F, McDonald PC, Lou Y, Vullo D, Scozzafava A, Dedhar S, Supuran CT (2011) Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J Med Chem 54:1896\u20131902","journal-title":"J Med Chem"},{"key":"15_CR46","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2174\/156802607780636735","volume":"7","author":"F Mincione","year":"2007","unstructured":"Mincione F, Scozzafava A, Supuran CT (2007) The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr Top Med Chem 7:849\u2013854","journal-title":"Curr Top Med Chem"},{"key":"15_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1517\/13543776.2012.649006","volume":"22","author":"F Carta","year":"2012","unstructured":"Carta F, Supuran CT, Scozzafava A (2012) Novel therapies for glaucoma: a patent review 2007\u20132011. Expert Opin Ther Pat 22:79\u201388","journal-title":"Expert Opin Ther Pat"},{"key":"15_CR48","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1016\/j.bmcl.2009.10.036","volume":"19","author":"RM Steele","year":"2009","unstructured":"Steele RM, Batugo MR, Benedini F, Borghi V, Carzaniga L, Impagnatiello F, Miglietta D, Chong WK, Rajapakse R, Cecchi A, Temperini C, Supuran CT (2009) Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma. Bioorg Med Chem Lett 19:6565\u20136570","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR49","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1016\/j.bmcl.2011.04.046","volume":"21","author":"F Mincione","year":"2011","unstructured":"Mincione F, Benedini F, Biondi S, Mincione F, Benedini F, Biondi S, Cecchi A, Temperini C, Formicola G, Pacileo I, Scozzafava A, Masini E, Supuran CT (2011) Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action. Bioorg Med Chem Lett 21:3216\u20133221","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR50","first-page":"73","volume-title":"Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications","author":"V Alterio","year":"2009","unstructured":"Alterio V, Di Fiore A, D\u2019Ambrosio K, Supuran CT, De Simone G (2009) X-Ray crystallography of CA inhibitors and its importance in drug design. In: Supuran CT, Winum JY (eds) Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications. Wiley, Hoboken, pp 73\u2013138"},{"key":"15_CR51","doi-asserted-by":"publisher","first-page":"8329","DOI":"10.1021\/ja061574s","volume":"128","author":"V Alterio","year":"2006","unstructured":"Alterio V, Vitale RM, Monti SM, Pedone C, Scozzafava A, Cecchi A, De Simone G, Supuran CT (2006) Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX. J Am Chem Soc 128:8329\u20138335","journal-title":"J Am Chem Soc"},{"key":"15_CR52","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1016\/j.bmcl.2007.05.045","volume":"17","author":"V Alterio","year":"2007","unstructured":"Alterio V, De Simone G, Monti SM, Scozzafava A, Supuran CT (2007) Carbonic anhydrase inhibitors: inhibition of human, bacterial, and archaeal isozymes with benzene-1,3-disulfonamides-solution and crystallographic studies. Bioorg Med Chem Lett 17:4201\u20134207","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR53","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1016\/j.bmc.2010.06.028","volume":"18","author":"J Wagner","year":"2010","unstructured":"Wagner J, Avvaru BS, Robbins AH, Scozzafava A, Supuran CT, McKenna R (2010) Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations. Bioorg Med Chem 18:4873\u20134878","journal-title":"Bioorg Med Chem"},{"key":"15_CR54","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1016\/j.bmc.2011.05.006","volume":"19","author":"S Biswas","year":"2011","unstructured":"Biswas S, Aggarwal M, Guzel O, Scozzafava A, McKenna R, Supuran CT (2011) Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms. Bioorg Med Chem 19:3732\u20133738","journal-title":"Bioorg Med Chem"},{"key":"15_CR55","doi-asserted-by":"publisher","first-page":"8371","DOI":"10.1039\/c0cc02707c","volume":"46","author":"F Pacchiano","year":"2010","unstructured":"Pacchiano F, Aggarwal M, Avvaru BS, Robbins AH, Scozzafava A, McKenna R, Supuran CT (2010) Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency. Chem Commun 46:8371\u20138373","journal-title":"Chem Commun"},{"key":"15_CR56","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1016\/j.bmc.2011.04.005","volume":"19","author":"F Carta","year":"2011","unstructured":"Carta F, Garaj V, Maresca A, Wagner J, Avvaru BS, Robbins AH, Scozzafava A, McKenna R, Supuran CT (2011) Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: solution and X-ray crystallographic studies. Bioorg Med Chem 19:3105\u20133119","journal-title":"Bioorg Med Chem"},{"key":"15_CR57","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1021\/jm200209n","volume":"54","author":"N Hen","year":"2011","unstructured":"Hen N, Bialer M, Yagen B, Aggarwal M, Robbins AH, McKenna R, Scozzafava A, Supuran CT (2011) Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII and XIV. J Med Chem 54:3977\u20133981","journal-title":"J Med Chem"},{"key":"15_CR58","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3109\/14756366.2011.554415","volume":"26","author":"S Kolayli","year":"2011","unstructured":"Kolayli S, Karahalil F, Sahin H, Dincer B, Supuran CT (2011) Characterization and inhibition studies of an \u03b1-carbonic anhydrase from the endangered sturgeon species Acipenser gueldenstaedti. J Enzyme Inhib Med Chem 26:895\u2013900","journal-title":"J Enzyme Inhib Med Chem"},{"key":"15_CR59","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1039\/c2cc16395k","volume":"48","author":"F Carta","year":"2012","unstructured":"Carta F, Aggarwal M, Maresca A, Scozzafava A, McKenna R, Supuran CT (2012) Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations. Chem Commun 48:1868\u20131870","journal-title":"Chem Commun"},{"key":"15_CR60","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.bmcl.2009.04.123","volume":"19","author":"\u00d6 G\u00fczel","year":"2009","unstructured":"G\u00fczel \u00d6, Innocenti A, Scozzafava A, Salman A, Supuran CT (2009) Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors. Bioorg Med Chem Lett 19:3170\u20133173","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR61","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1016\/j.bmc.2009.06.006","volume":"17","author":"\u00d6 G\u00fczel","year":"2009","unstructured":"G\u00fczel \u00d6, Innocenti A, Scozzafava A, Salman A, Supuran CT (2009) Carbonic anhydrase inhibitors. Aromatic\/heterocyclic sulfonamides incorporating phenacetyl-, pyridylacetyl- and thienylacetyl- tails act as potent inhibitors of human mitochondrial isoforms VA and VB. Bioorg Med Chem 17:4894\u20134899","journal-title":"Bioorg Med Chem"},{"key":"15_CR62","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3109\/14756369909030328","volume":"14","author":"A Scozzafava","year":"1999","unstructured":"Scozzafava A, Supuran CT (1999) Carbonic anhydrase inhibitors. Arylsulfonylureido and arylureido-substituted aromatic and heterocyclic sulfonamides: towards selective inhibitors of carbonic anhydrase isozyme I. J Enzyme Inhib 14:343\u2013363","journal-title":"J Enzyme Inhib"},{"key":"15_CR63","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1016\/j.bmcl.2004.07.087","volume":"14","author":"V Garaj","year":"2004","unstructured":"Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT (2004) Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic\/tumor-associated carbonic anhydrase isozymes I, II and IX with sulfonamides incorporating 1,2,4-triazine moieties. Bioorg Med Chem Lett 14:5427\u20135433","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR64","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1016\/j.bmcl.2005.04.056","volume":"15","author":"V Garaj","year":"2005","unstructured":"Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT (2005) Carbonic anhydrase inhibitors. Novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II and IX. Bioorg Med Chem Lett 15:3102\u20133108","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR65","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","volume":"3","author":"PC McDonald","year":"2012","unstructured":"McDonald PC, Winum JY, Supuran CT, Dedhar S (2012) Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. Oncotarget 3:84\u201397","journal-title":"Oncotarget"},{"key":"15_CR66","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1021\/jm300031j","volume":"55","author":"F Carta","year":"2012","unstructured":"Carta F, Aggarwal M, Maresca A, Scozzafava A, McKenna R, Masini E, Supuran CT (2012) Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo. J Med Chem 55:1721\u20131730","journal-title":"J Med Chem"},{"key":"15_CR67","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.bmcl.2011.12.033","volume":"22","author":"SM Monti","year":"2012","unstructured":"Monti SM, Maresca A, Viparelli F, Carta F, De Simone G, M\u00fchlschlegel FA, Scozzafava A, Supuran CT (2012) Dithiocarbamates strongly inhibit the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata. Bioorg Med Chem Lett 22:859\u2013862","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR68","doi-asserted-by":"crossref","unstructured":"Maresca A, Carta F, Vullo D, Supuran CT (2013) Dithiocarbamates strongly inhibit the beta-class carbonic anhydrases from Mycobacterium tuberculosis. J Enzyme Inhib Med Chem 28 (in press)","DOI":"10.3109\/14756366.2011.650168"},{"key":"15_CR69","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/9780470508169.ch14","volume-title":"Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications","author":"RA Hall","year":"2009","unstructured":"Hall RA, M\u00fchlschlegel FA (2009) Fungal and nematode carbonic anhydrases: their inhibition in drug design. In: Supuran CT, Winum JY (eds) Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications. Wiley, Hoboken, pp 301\u2013322"},{"key":"15_CR70","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/9780470508169.ch15","volume-title":"Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications","author":"UM Ohndorf","year":"2009","unstructured":"Ohndorf UM, Schlicker C, Steegborn C (2009) Crystallographic studies on carbonic anhydrases from fungal pathogens for structure-assisted drug development. In: Supuran CT, Winum JY (eds) Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications. Wiley, Hoboken, pp 323\u2013334"},{"key":"15_CR71","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1016\/j.bmcl.2011.02.057","volume":"21","author":"F Carta","year":"2011","unstructured":"Carta F, Innocenti A, Hall RA, M\u00fchlschlegel FA, Scozzafava A, Supuran CT (2011) Carbonic anhydrase inhibitors. Inhibition of the \u03b2-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with branched aliphatic-\/aromatic carboxylates and their derivatives. Bioorg Med Chem Lett 21:2521\u20132526","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR72","doi-asserted-by":"publisher","first-page":"622","DOI":"10.2174\/138161208783877875","volume":"14","author":"I Nishimori","year":"2008","unstructured":"Nishimori I, Onishi S, Takeuchi H, Supuran CT (2008) The \u03b1 and \u03b2 classes carbonic anhydrases from Helicobacter pylori as novel drug targets. Curr Pharm Des 14:622\u2013630","journal-title":"Curr Pharm Des"},{"key":"15_CR73","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1021\/jm9000488","volume":"52","author":"T Minakuchi","year":"2009","unstructured":"Minakuchi T, Nishimori I, Vullo D, Scozzafava A, Supuran CT (2009) Molecular cloning, characterization and inhibition studies of the Rv1284 \u03b2-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate. J Med Chem 52:2226\u20132232","journal-title":"J Med Chem"},{"key":"15_CR74","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1021\/jm9003126","volume":"52","author":"I Nishimori","year":"2009","unstructured":"Nishimori I, Minakuchi T, Vullo D, Scozzafava A, Innocenti A, Supuran CT (2009) Carbonic anhydrase inhibitors. cloning, characterization, and inhibition studies of a new \u03b2-carbonic anhydrase from Mycobacterium tuberculosis. J Med Chem 52:3116\u20133120","journal-title":"J Med Chem"},{"key":"15_CR75","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1021\/jm9004016","volume":"52","author":"\u00d6 G\u00fczel","year":"2009","unstructured":"G\u00fczel \u00d6, Maresca A, Scozzafava A, Salman A, Balaban AT, Supuran CT (2009) Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial \u03b2-carbonic anhydrases Rv1284 and Rv3273. J Med Chem 52:4063\u20134067","journal-title":"J Med Chem"},{"key":"15_CR76","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.1016\/j.bmcl.2009.10.009","volume":"19","author":"F Carta","year":"2009","unstructured":"Carta F, Maresca A, Suarez Covarrubias A, Mowbray SL, Jones TA, Supuran CT (2009) Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active \u03b2-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c. Bioorg Med Chem Lett 19:6649\u20136654","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR77","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.2174\/138161210793429814","volume":"16","author":"I Nishimori","year":"2010","unstructured":"Nishimori I, Minakuchi T, Maresca A, Carta F, Scozzafava A, Supuran CT (2010) The \u03b2-carbonic anhydrases from Mycobacterium tuberculosis as drug targets. Curr Pharm Des 16:3300\u20133309","journal-title":"Curr Pharm Des"},{"key":"15_CR78","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.2174\/138161210793429850","volume":"16","author":"JY Winum","year":"2010","unstructured":"Winum JY, Kohler S, Supuran CT (2010) Brucella carbonic anhydrases: new targets for designing anti-infective agents. Curr Pharm Des 16:3310\u20133316","journal-title":"Curr Pharm Des"},{"key":"15_CR79","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1016\/j.bmcl.2011.04.105","volume":"21","author":"D Vullo","year":"2011","unstructured":"Vullo D, Nishimori I, Minakuchi T, Scozzafava A, Supuran CT (2011) Inhibition studies with anions and small molecules of two novel \u03b2-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium. Bioorg Med Chem Lett 21:3591\u20133595","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR80","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1110\/ps.46301","volume":"10","author":"JD Cronk","year":"2001","unstructured":"Cronk JD, Endrizzi JA, Cronk MR, O'Neill JW, Zhang K (2001) Crystal structure of E. coli b-carbonic anhydrase, an enzyme with an unusual pH-dependent activity. Protein Sci 10:911\u2013922","journal-title":"Protein Sci"},{"key":"15_CR81","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1021\/bi052272q","volume":"45","author":"JD Cronk","year":"2006","unstructured":"Cronk JD, Rowlett RS, Zhang KY, Tu C, Endrizzi JA, Lee J, Gareiss PC, Preiss JR (2006) Identification of a novel noncatalytic bicarbonate binding site in eubacterial \u03b2-carbonic anhydrase. Biochemistry 45:4351\u20134361","journal-title":"Biochemistry"},{"key":"15_CR82","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3109\/14756366.2011.649268","volume":"28","author":"A Maresca","year":"2013","unstructured":"Maresca A, Vullo D, Scozzafava A, Supuran CT (2013) Inhibition of the alpha- and beta- carbonic anhydrases from the gastric pathogen Helycobacter pylori with anions. J Enzyme Inhib Med Chem 28:388\u2013891","journal-title":"J Enzyme Inhib Med Chem"},{"key":"15_CR83","doi-asserted-by":"crossref","unstructured":"Maresca A, Vullo D, Scozzafava A, Manole G, Supuran CT (2013) Inhibition of the beta-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids. J Enzyme Inhib Med Chem 28 (in press)","DOI":"10.3109\/14756366.2011.650168"},{"key":"15_CR84","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.bmcl.2010.02.042","volume":"20","author":"D Vullo","year":"2010","unstructured":"Vullo D, Nishimori I, Scozzafava A, K\u00f6hler S, Winum JY, Supuran CT (2010) Inhibition studies of a \u03b2-carbonic anhydrase from Brucella suis with a series of water soluble glycosyl sulfanilamides. Bioorg Med Chem Lett 20:2178\u20132182","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR85","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1016\/j.bmcl.2007.04.063","volume":"17","author":"I Nishimori","year":"2007","unstructured":"Nishimori I, Minakuchi T, Kohsaki T, Onishi S, Takeuchi H, Vullo D, Scozzafava A, Supuran CT (2007) Carbonic anhydrase inhibitors. The \u03b2-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors. Bioorg Med Chem Lett 17:3585\u20133594","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR86","doi-asserted-by":"publisher","first-page":"10742","DOI":"10.1021\/jm301611m","volume":"55","author":"S Del Prete","year":"2012","unstructured":"Del Prete S, Isik S, Vullo D, De Luca V, Carginale V, Scozzafava A, Supuran CT, Capasso C (2012) DNA cloning, characterization and inhibition studies of an \u03b1-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J Med Chem 55:10742\u201310748","journal-title":"J Med Chem"},{"key":"15_CR87","doi-asserted-by":"crossref","unstructured":"Buchieri MV, Riafrecha LE, Rodr\u00edguez OM, Vullo D, Morbidoni HR, Supuran CT, Colinas PA (2013) Inhibition of the \u03b2-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: identification of the first inhibitor with antimycobacterial activity. Bioorg Med Chem Lett 23 (in press)","DOI":"10.1016\/j.bmcl.2012.11.085"},{"key":"15_CR88","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1021\/ja00087a086","volume":"116","author":"SK Nair","year":"1994","unstructured":"Nair SK, Ludwig PA, Christianson DW (1994) Two-site binding of phenol in the active site of human carbonic anhydrase II: structural implications for substrate association. J Am Chem Soc 116:3659\u20133660","journal-title":"J Am Chem Soc"},{"key":"15_CR89","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.bmcl.2008.01.077","volume":"18","author":"A Innocenti","year":"2008","unstructured":"Innocenti A, Vullo D, Scozzafava A, Supuran CT (2008) Carbonic anhydrase inhibitors. Interactions of phenols with the 12 catalytically active mammalian isoforms (CA I \u2013 XIV). Bioorg Med Chem Lett 18:1583\u20131587","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR90","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1016\/j.bmcl.2008.04.077","volume":"18","author":"A Innocenti","year":"2008","unstructured":"Innocenti A, Hilvo M, Scozzafava A, Parkkila S, Supuran CT (2008) Carbonic anhydrase inhibitors. Inhibition of the new membrane-associated isoform XV with phenols. Bioorg Med Chem Lett 18:3593\u20133596","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR91","doi-asserted-by":"publisher","first-page":"7424","DOI":"10.1016\/j.bmc.2008.06.013","volume":"16","author":"A Innocenti","year":"2008","unstructured":"Innocenti A, Vullo D, Scozzafava A, Supuran CT (2008) Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I \u2013 XIV with a series of substituted phenols including paracetamol and salicylic acid. Bioorg Med Chem 16:7424\u20137428","journal-title":"Bioorg Med Chem"},{"key":"15_CR92","doi-asserted-by":"publisher","first-page":"9101","DOI":"10.1016\/j.bmc.2008.09.028","volume":"16","author":"E Bayram","year":"2008","unstructured":"Bayram E, Senturk M, Kufrevioglu OI, Supuran CT (2008) In vitro effects of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II. Bioorg Med Chem 16:9101\u20139105","journal-title":"Bioorg Med Chem"},{"key":"15_CR93","doi-asserted-by":"crossref","unstructured":"Carta F, Vullo D, Maresca A, Scozzafava A, Supuran CT (2013) Mono-\/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV. Bioorg Med Chem 21 (in press)","DOI":"10.1016\/j.bmc.2012.05.019"},{"key":"15_CR94","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1039\/c2cc32013d","volume":"48","author":"DP Martin","year":"2012","unstructured":"Martin DP, Cohen SM (2012) Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors. Chem Commun 48:5259\u20135261","journal-title":"Chem Commun"},{"key":"15_CR95","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1016\/j.bmc.2012.02.014","volume":"20","author":"F Carta","year":"2012","unstructured":"Carta F, Maresca A, Scozzafava A, Supuran CT (2012) Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII. Bioorg Med Chem 20:2266\u20132273","journal-title":"Bioorg Med Chem"},{"key":"15_CR96","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/j.bmcl.2012.01.129","volume":"22","author":"F Carta","year":"2012","unstructured":"Carta F, Vullo D, Maresca A, Scozzafava A, Supuran CT (2012) New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II. Bioorg Med Chem Lett 22:2182\u20132185","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR97","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1016\/j.bmcl.2010.06.040","volume":"20","author":"A Maresca","year":"2010","unstructured":"Maresca A, Supuran CT (2010) Coumarins incorporating hydroxy- and chloro- moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II. Bioorg Med Chem Lett 20:4511\u20134514","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR98","doi-asserted-by":"publisher","first-page":"7255","DOI":"10.1016\/j.bmcl.2010.10.094","volume":"20","author":"A Maresca","year":"2010","unstructured":"Maresca A, Scozzafava A, Supuran CT (2010) 7,8-Disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar\/subnanomolar range. Bioorg Med Chem Lett 20:7255\u20137258","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR99","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.bmc.2012.07.021","volume":"21","author":"RA Davis","year":"2013","unstructured":"Davis RA, Vullo D, Maresca A, Supuran CT, Poulsen SA (2013) Natural product coumarins that inhibit human carbonic anhydrases. Bioorg Med Chem 21:1539\u20131543","journal-title":"Bioorg Med Chem"},{"key":"15_CR100","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bmcl.2011.11.018","volume":"22","author":"F Carta","year":"2012","unstructured":"Carta F, Maresca A, Scozzafava A, Supuran CT (2012) 5- and 6-Membered (thio)lactones are prodrug type carbonic anhydrase inhibitors. Bioorg Med Chem Lett 22:267\u2013270","journal-title":"Bioorg Med Chem Lett"},{"key":"15_CR101","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1021\/jm301625s","volume":"56","author":"K Tars","year":"2013","unstructured":"Tars K, Vullo D, Kazaks A, Leitans J, Lends A, Grandane A, Zalubovskis R, Scozzafava A, Supuran CT (2013) Sulfocoumarins (1,2-benzoxathiine 2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases. J Med Chem 56:293\u2013300","journal-title":"J Med Chem"},{"key":"15_CR102","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3109\/14756366.2012.737323","volume":"28","author":"M Aggarwal","year":"2013","unstructured":"Aggarwal M, Boone CD, Kondeti B, McKenna R (2013) Structural annotations of human carbonic anhydrases. J Enzyme Inhib Med Chem 28:267\u2013277","journal-title":"J Enzyme Inhib Med Chem"},{"key":"15_CR103","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.bmc.2012.08.019","volume":"21","author":"M Aggarwal","year":"2013","unstructured":"Aggarwal M, Kondeti B, McKenna R (2013) Insights towards sulfonamide drug specificity in \u03b1-carbonic anhydrases. Bioorg Med Chem 21:1526\u20131533","journal-title":"Bioorg Med Chem"}],"container-title":["Subcellular Biochemistry","Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-007-7359-2_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T17:59:57Z","timestamp":1675965597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-007-7359-2_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,17]]},"ISBN":["9789400773585","9789400773592"],"references-count":103,"URL":"https:\/\/doi.org\/10.1007\/978-94-007-7359-2_15","relation":{},"ISSN":["0306-0225"],"issn-type":[{"value":"0306-0225","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,17]]},"assertion":[{"value":"17 September 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}